Loading clinical trials...
Loading clinical trials...
A 24-week, Randomized, Open-label, 2-arm Study to Compare the Safety, Efficacy and Tolerability of Invirase® Tablets With Ritonavir Versus Kaletra® Tablets in HIV 1 Infected Adults on a Kaletra® Based Regimen With 2 Nucleosides/Nucleotides
Conditions
Interventions
Saquinavir (Invirase®)
Lopinavir/ritonavir (Kaletra®)
Locations
1
United Kingdom
Royal Free Hampstead NHS Trust
London, United Kingdom
Start Date
September 1, 2006
Primary Completion Date
February 1, 2009
Completion Date
February 1, 2009
Last Updated
July 18, 2011
NCT06694805
NCT04142047
NCT07428330
NCT07225530
NCT06665646
NCT05897099
Lead Sponsor
Royal Free Hampstead NHS Trust
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions